Table: Cosmos Pharmaceutical -2017/18 group results

Cosmos Pharmaceutical

12/07/2018 07:00

Jul 12 (Reuters)- 
          Cosmos Pharmaceutical Corp. 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              May 31, 2018    May 31, 2017   May 31, 2019     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales          558.00          502.73         610.00        298.70   
               (+11.0 pct)     (+12.4 pct)    (+9.3 pct)   (+10.3 pct) 
  Operating       22.75           22.24          23.00         10.80   
               (+2.3 pct)      (+19.2 pct)    (+1.1 pct)    (+4.9 pct) 
  Recurring       25.26           24.59          25.50         12.10   
               (+2.7 pct)      (+18.8 pct)    (+1.0 pct)    (+4.4 pct) 
  Net
  Net             17.63           18.22          17.65          8.23   
               (-3.2 pct)      (+46.5 pct)    (+0.1 pct)    (+5.7 pct) 
  EPS          890.59 yen      919.99 yen     891.43 yen    415.56 yen 
  Ann Div       90.00 yen       80.00 yen      90.00 yen               
  -Q2 Div       45.00 yen       35.00 yen      45.00 yen               
  -Q4 Div       45.00 yen       45.00 yen      45.00 yen               
  
  NOTE - Cosmos Pharmaceutical Corp..
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T